|
Table 2: Blood loss, hematologic data, and allogeneic blood transfusions. |
|||
|
Total knee arthroplasty |
|||
|
Control group N = 80 |
Tranexamic acid group N = 68 |
p* |
|
|
Preoperative Hb‡ |
13.36 ± 1.43 |
13.54 ± 1.26 |
|
|
POD 1 Hb‡ |
10.44 ± 1.46 |
11.83 ± 1.18 |
≤ 0.001 |
|
Hb Reduction‡ |
2.92 ± 0.93 |
1.71 ± 0.82 |
|
|
Packed RBC transfusions |
23 PC |
2 PC |
≤ 0.001 |
|
1 PC, (patients) |
9 |
2 |
|
|
2 PC, (patients) |
4 |
||
|
3 PC, (patients) |
1 |
||
|
Non-risk vs previous VTE PC consumption, (patients) |
(5 vs 9) |
(2 vs 0) |
|
|
Post-op complications |
2 (pulmonary embolism) |
Non |
|
|
Total hip arthroplasty |
|||
|
Control group N = 84 |
Tranexamic acid group N = 50 |
p* |
|
|
Preoperative Hb‡ |
13.11 ± 1.22 |
13.49 ± 1.55 |
|
|
POD 1 Hb‡ |
10.34 ± 1.23 |
11.31 ± 1.39 |
≤ 0.001 |
|
Hb Reduction‡ |
2.76 ± 0.88 |
2.179 ± 1.08 |
|
|
Packed RBC transfusions |
17 PC |
2 |
≤ 0.001 |
|
1 PC, (patients) |
10 |
2 |
|
|
2 PC, (patients) |
2 |
||
|
3 PC, (patients) |
1 |
||
|
Non-risk vs. previous VTE PC consumption, (patients) |
(9 vs. 4) |
(2 vs. 0) |
|
|
Post-op complications |
Non |
Non |
|
|
* p-values. ‡ Mean ± standard deviation. PC = packed cells. POD 1 Hb = post-operative day one hemoglobin. RBC = red blood cells. VTE = venous thromboembolism. |
|||